BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
8.9650
14-February-25 11:13:12
15 minutes delayed
Stocks
+0.1450
+1.64%
Today's range
8.7200 - 9.0000
ISIN
N/A
Source
NASDAQ
-
22 Jun 2022 06:00:02 By Nasdaq GlobeNewswire
-
BioCryst Selects Pint Pharma as Commercial Partner for ORLADEYO® (berotralstat) in Latin America
09 Jun 2022 06:00:00 By Nasdaq GlobeNewswire
-
FDA Grants Fast Track Designation for BioCryst’s ALK-2 Inhibitor, BCX9250
08 Jun 2022 06:00:01 By Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by Swissmedic
07 Jun 2022 08:00:02 By Nasdaq GlobeNewswire
-
06 Jun 2022 06:00:30 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
01 Jun 2022 06:00:15 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
06 May 2022 06:00:28 By Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
05 May 2022 06:00:11 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 May 2022 15:15:39 By Nasdaq GlobeNewswire
-
27 Apr 2022 06:00:00 By Nasdaq GlobeNewswire